Capital Research Global Investors
PRAH

Capital Research Global Investors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Capital Research Global Investors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,298,597
Closed -$380M – 459
2021
Q2 		$380M Sell
2,298,597
-1,127,045
-33% -$188M 0.09% 195
2021
Q1 		$525M Sell
3,425,642
-25,034
-0.7% -$3.4M 0.13% 155
2020
Q4 		$433M Buy
3,450,676
+28,605
+0.8% +$3.2M 0.11% 168
2020
Q3 		$347M Buy
3,422,071
+245,979
+8% +$25.1M 0.1% 168
2020
Q2 		$309M Sell
3,176,092
-129,195
-4% -$12M 0.1% 163
2020
Q1 		$274M Buy
3,305,287
+729,301
+28% +$71.1M 0.11% 157
2019
Q4 		$286M Sell
2,575,986
-176,803
-6% -$18.2M 0.09% 184
2019
Q3 		$273M Sell
2,752,789
-1,478,657
-35% -$147M 0.09% 181
2019
Q2 		$420M Buy
4,231,446
+482,211
+13% +$46M 0.13% 147
2019
Q1 		$414M Sell
3,749,235
-9
-0% -$941 0.13% 154
2018
Q4 		$345M Sell
3,749,244
-204,778
-5% -$20.7M 0.12% 156
2018
Q3 		$436M Buy
3,954,022
+97
+0% +$10.1K 0.13% 150
2018
Q2 		$369M Sell
3,953,925
-516,606
-12% -$44.5M 0.1% 172
2018
Q1 		$371M Buy
4,470,531
+920,702
+26% +$81.8M 0.11% 168
2017
Q4 		$323M Buy
3,549,829
+846,848
+31% +$70.4M 0.09% 178
2017
Q3 		$206M Buy
2,702,981
+527,641
+24% +$39.9M 0.06% 223
2017
Q2 		$163M Buy
2,175,340
+1,655,336
+318% +$115M 0.05% 249
2017
Q1 		$33.9M Buy
+520,004
New +$30.6M 0.01% 359

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Capital Research Global Investors's PRAH Position: Q3 2021 in Review

Capital Research Global Investors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,298,597 shares — an estimated $380M sold.

Capital Research Global Investors first reported a position in PRAH in Q1 2017 and held it in 18 quarters. The position peaked at $525M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Capital Research Global Investors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Capital Research Global Investors sold 2,298,597 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $380M.
  • Capital Research Global Investors first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 18 quarters.
  • Capital Research Global Investors's PRA Health Sciences, Inc. position peaked at $525M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Capital Research Global Investors's 13F filing for Q3 2021, filed 15 Nov 2021.